Skip to main content
Caplight Logo









Dama Health

Dama Health

Private
LondonHealthcare & Life Scienceshttps://www.damahealth.com/

Last Round

Grant

Oct 23, 2024

Total Funding Raised

$3.25M

Company Overview

Dama Health is a healthtech company that develops pharmacogenetic technology and clinical decision support tools to provide personalized hormone therapy recommendations for women's health.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Patient Engagement, Vertical SaaS, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportfemtechprecision medicinehormonal healthpharmacogenomicsPGxvertical SaaSdigital healthhealthcare analyticspatient engagementmedical AIclinical softwarebiomarker integrationpersonalized medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dama Health Comparables

Compare Dama Health with similar companies based on industry and business-model similarity.

Dama Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SymptoLab
78%
The Lowdown
62%
adyn
55%

Dama Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 23, 2024
AcceleratorJun 24, 2024
AcceleratorNov 8, 2022
AcceleratorSep 14, 2022

Key People

Founding team and executive leadership

Elena Rueda

Co-Founder & CEO

Founding Team

Dama Health Investors

Notable investors and investment history

Dama Health investors
InvestorRounds
KQ LabsAccelerator
The Francis Crick InstituteAccelerator
ARPA-HGrant
LifeArcAccelerator
Cancer Research HorizonsAccelerator
Illumina AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors grew 74% MoM, reaching 3.9K.

  • Jun 2, 2025

    Monthly visitors increased 32% MoM, reaching 2.9K.

Dama Health Filings

Explore SEC and related filing metadata, where available.

Dama Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dama Health's valuation, stock price, and market status.

Is Dama Health a public or private company?

Dama Health is a private company.

What is the current stock price of Dama Health?

Dama Health is a private company with no public stock price. No recent secondary market data is available.

How much is Dama Health worth (valuation)?

Valuation information for Dama Health is not publicly available.

Can I buy Dama Health stock?

Dama Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dama Health's last funding round?

Dama Health's most recent funding round was Grant on October 23, 2024.

Who are the main investors in Dama Health?

Key investors in Dama Health include KQ Labs, ARPA-H, Illumina Accelerator.

Will Dama Health IPO soon?

No public IPO plans have been announced for Dama Health.

How can I track Dama Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dama Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range16
Year Founded2021
Last FundingOct 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?